Stockreport

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Prenetics Global Limited - Class A Ordinary Share  (PRE) 
PDF HONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, [Read more]